Results 241 to 250 of about 164,343 (265)

Triple negative breast cancer and non-small cell lung cancer: Clinical challenges and nano-formulation approaches.

Journal of Controlled Release, 2021
Saikat Ghosh, Ankit Javia, Saritha Shetty, Denish Bardoliwala, K. Maiti, Shubhadeep Banerjee, Ajay Khopade, A. Misra, K. Sawant, S. Bhowmick   +9 more
semanticscholar   +1 more source

Immune checkpoint inhibitors for triple-negative breast cancer: From immunological mechanisms to clinical evidence.

International Immunopharmacology, 2021
Melina Farshbafnadi, Amin Pastaki Khoshbin, N. Rezaei   +2 more
semanticscholar   +1 more source

Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer

Ca-A Cancer Journal for Clinicians, 2023
Hope Rugo, Laura Huppert
exaly  

Triple Negative Breast Cancer: Updates on Classification and Treatment in 2021

Cancers, 2022
Rola F Jaafar, Zeina Nahleh, Nadeem Bilani   +2 more
exaly  

Triple-negative breast cancer: biology, pathology, and treatment

, 2021
A. Miri, E. Kiani, S. Habibi, M. Khafaei
semanticscholar   +1 more source

Breast Cancer Statistics, 2022

Ca-A Cancer Journal for Clinicians, 2022
, Kimberly Miller, Hyuna Sung
exaly  

Systemic Therapy for Metastatic Triple Negative Breast Cancer: Current Treatments and Future Directions

Cancers, 2023
Alicia Okines, Laura Morrison, Okines Alicia   +2 more
exaly  

Pathogenesis of Triple-Negative Breast Cancer

Annual Review of Pathology: Mechanisms of Disease, 2022
Fatemeh Derakhshan, Jorge Reis-Filho
exaly  

Metabolic Reprogramming in Triple-Negative Breast Cancer

Frontiers in Oncology, 2020
Jingyi Guo, Mozhi Wang, Yu Xueting
exaly  

A Novel Immunomodulatory 27-Gene Signature to Predict Response to Neoadjuvant Immunochemotherapy for Primary Triple-Negative Breast Cancer

Cancers, 2021
Xiang Zhang, Kim Rm Blenman, David Hout   +2 more
exaly